Biotech Investors & VC Firms in China

125 firms in this list, with a median first check of $1M. 5 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
China Growth Capital 3 people · Leads rounds	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
dsm-firmenich Venturing 9 people	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
EDB Investments 11 people	—	SG	Seed–Series B	—	+ Add to CRM
JAFCO Group 8 people	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
Cowin Capital Group 11 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
Darwin Venture Management 8 people	Taipei	TW	Seed–Late Stage	$1M – $5M	+ Add to CRM
Fortune Venture Capital 11 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
MPCi (formerly Matrix Partners China) 11 people	Singapore	CN	Seed–Growth	—	+ Add to CRM
VantagePoint Capital Partners 8 people	Santa Barbara	US	Seed–Late Stage	$2M – $100M	+ Add to CRM
Infotech Ventures	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
Pivotal Life Sciences 10 people	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
JAFCO Asia 9 people	Beijing	SG	Seed–Late Stage	—	+ Add to CRM
Boehringer Ingelheim Venture Fund 9 people	Ingelheim am Rhein	DE	Seed–Series B	$16.2M	+ Add to CRM
Detong Capital 9 people	Shanghai	CN	Seed–Series B	$20M	+ Add to CRM
Hony Capital Ltd. 6 people	Beijing	CN	Growth–Late Stage	$6M	+ Add to CRM
Sycamore Ventures 6 people	Princeton	US	Growth	$5M – $20M	+ Add to CRM
TCG Crossover 8 people	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
Co-Win Ventures 8 people	Suzhou	CN	Seed–Series B	—	+ Add to CRM
NewMargin Ventures 5 people	Shanghai	CN	Seed–Late Stage	$500K – $5M	+ Add to CRM
Volcanics Venture 8 people	Shanghai	CN	Seed–Series B	—	+ Add to CRM
Biomark Capital 4 people	Greenwich	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
Capital Group Private Markets 4 people	—	SG	Growth	$12M – $100M	+ Add to CRM
CDF-Capital 7 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
Delos Capital 7 people	Cambridge	US	Seed–Late Stage	—	+ Add to CRM